PMID- 19858416 OWN - NLM STAT- MEDLINE DCOM- 20091207 LR - 20220311 IS - 1524-4539 (Electronic) IS - 0009-7322 (Print) IS - 0009-7322 (Linking) VI - 120 IP - 19 DP - 2009 Nov 10 TI - Hyperhomocysteinemia promotes inflammatory monocyte generation and accelerates atherosclerosis in transgenic cystathionine beta-synthase-deficient mice. PG - 1893-902 LID - 10.1161/CIRCULATIONAHA.109.866889 [doi] AB - BACKGROUND: Hyperhomocysteinemia (HHcy) is an independent risk factor for cardiovascular disease. Monocytes display inflammatory and resident subsets and commit to specific functions in atherogenesis. In this study, we examined the hypothesis that HHcy modulates monocyte heterogeneity and leads to atherosclerosis. METHODS AND RESULTS: We established a novel atherosclerosis-susceptible mouse model with both severe HHcy and hypercholesterolemia in which the mouse cystathionine beta-synthase (CBS) and apolipoprotein E (apoE) genes are deficient and an inducible human CBS transgene is introduced to circumvent the neonatal lethality of the CBS deficiency (Tg-hCBS apoE(-/-) Cbs(-/-) mice). Severe HHcy accelerated atherosclerosis and inflammatory monocyte/macrophage accumulation in lesions and increased plasma tumor necrosis factor-alpha and monocyte chemoattractant protein-1 levels in Tg-hCBS apoE(-/-) Cbs(-/-) mice fed a high-fat diet. Furthermore, we characterized monocyte heterogeneity in Tg-hCBS apoE(-/-) Cbs(-/-) mice and another severe HHcy mouse model (Tg-S466L Cbs(-/-)) with a disease-relevant mutation (Tg-S466L) that lacks hyperlipidemia. HHcy increased monocyte population and selective expansion of inflammatory Ly-6C(hi) and Ly-6C(mid) monocyte subsets in blood, spleen, and bone marrow of Tg-S466L Cbs(-/-) and Tg-hCBS apoE(-/-) Cbs(-/-) mice. These changes were exacerbated in Tg-S466L Cbs(-/-) mice with aging. Addition of l-homocysteine (100 to 500 micromol/L), but not l-cysteine, maintained the Ly-6C(hi) subset and induced the Ly-6C(mid) subset in cultured mouse primary splenocytes. Homocysteine-induced differentiation of the Ly-6C(mid) subset was prevented by catalase plus superoxide dismutase and the NAD(P)H oxidase inhibitor apocynin. CONCLUSIONS: HHcy promotes differentiation of inflammatory monocyte subsets and their accumulation in atherosclerotic lesions via NAD(P)H oxidase-mediated oxidant stress. FAU - Zhang, Daqing AU - Zhang D AD - Department of Pharmacology and Cardiovascular Research Center, Temple University School of Medicine, Philadelphia, PA 19140, USA. FAU - Jiang, Xiaohua AU - Jiang X FAU - Fang, Pu AU - Fang P FAU - Yan, Yan AU - Yan Y FAU - Song, Jian AU - Song J FAU - Gupta, Sapna AU - Gupta S FAU - Schafer, Andrew I AU - Schafer AI FAU - Durante, William AU - Durante W FAU - Kruger, Warren D AU - Kruger WD FAU - Yang, Xiaofeng AU - Yang X FAU - Wang, Hong AU - Wang H LA - eng GR - R01 HL077288-06/HL/NHLBI NIH HHS/United States GR - R01 HL077288/HL/NHLBI NIH HHS/United States GR - AHA0555423U/PHS HHS/United States GR - HL74966/HL/NHLBI NIH HHS/United States GR - R01 HL074966/HL/NHLBI NIH HHS/United States GR - HL77288/HL/NHLBI NIH HHS/United States GR - R01 HL117654/HL/NHLBI NIH HHS/United States GR - HL67033/HL/NHLBI NIH HHS/United States GR - HL094451/HL/NHLBI NIH HHS/United States GR - R01 HL082774/HL/NHLBI NIH HHS/United States GR - R29 HL057299/HL/NHLBI NIH HHS/United States GR - R01 DK104116/DK/NIDDK NIH HHS/United States GR - HL57299/HL/NHLBI NIH HHS/United States GR - HL36045/HL/NHLBI NIH HHS/United States GR - R01 HL057299/HL/NHLBI NIH HHS/United States GR - R01 HL082774-04/HL/NHLBI NIH HHS/United States GR - R01 HL067033/HL/NHLBI NIH HHS/United States GR - R01 HL067033-07S1/HL/NHLBI NIH HHS/United States GR - HL82774/HL/NHLBI NIH HHS/United States GR - R01 HL094451/HL/NHLBI NIH HHS/United States GR - R01 HL036045/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20091026 PL - United States TA - Circulation JT - Circulation JID - 0147763 RN - 0 (Apolipoproteins E) RN - 0 (Ccl2 protein, mouse) RN - 0 (Chemokine CCL2) RN - 0 (Tumor Necrosis Factor-alpha) RN - EC 4.2.1.22 (Cystathionine beta-Synthase) SB - IM MH - Animals MH - Apolipoproteins E/genetics MH - Atherosclerosis/*immunology/metabolism/pathology MH - Body Weight MH - Cells, Cultured MH - Chemokine CCL2/blood MH - Cystathionine beta-Synthase/*genetics/metabolism MH - Disease Models, Animal MH - Female MH - Homocystinuria/*immunology/metabolism/pathology MH - Humans MH - Hyperhomocysteinemia/*immunology/metabolism/pathology MH - Macrophages/immunology/pathology MH - Mice MH - Mice, Inbred C57BL MH - Mice, Transgenic MH - Monocytes/*immunology/pathology MH - Oxidative Stress/physiology MH - Pregnancy MH - Severity of Illness Index MH - Spleen/cytology MH - Tumor Necrosis Factor-alpha/blood MH - Vasculitis/immunology/metabolism/pathology PMC - PMC2783582 MID - NIHMS153737 EDAT- 2009/10/28 06:00 MHDA- 2009/12/16 06:00 PMCR- 2010/11/10 CRDT- 2009/10/28 06:00 PHST- 2009/10/28 06:00 [entrez] PHST- 2009/10/28 06:00 [pubmed] PHST- 2009/12/16 06:00 [medline] PHST- 2010/11/10 00:00 [pmc-release] AID - CIRCULATIONAHA.109.866889 [pii] AID - 10.1161/CIRCULATIONAHA.109.866889 [doi] PST - ppublish SO - Circulation. 2009 Nov 10;120(19):1893-902. doi: 10.1161/CIRCULATIONAHA.109.866889. Epub 2009 Oct 26.